| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 8 |
| NetGPI | no | yes: 0, no: 8 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.691 |
| CLV_NRD_NRD_1 | 21 | 23 | PF00675 | 0.617 |
| CLV_NRD_NRD_1 | 62 | 64 | PF00675 | 0.513 |
| CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.703 |
| CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.707 |
| CLV_PCSK_KEX2_1 | 33 | 35 | PF00082 | 0.620 |
| CLV_PCSK_KEX2_1 | 75 | 77 | PF00082 | 0.551 |
| CLV_PCSK_PC1ET2_1 | 12 | 14 | PF00082 | 0.703 |
| CLV_PCSK_PC1ET2_1 | 3 | 5 | PF00082 | 0.707 |
| CLV_PCSK_PC1ET2_1 | 33 | 35 | PF00082 | 0.620 |
| CLV_PCSK_PC1ET2_1 | 75 | 77 | PF00082 | 0.626 |
| CLV_PCSK_SKI1_1 | 22 | 26 | PF00082 | 0.619 |
| CLV_PCSK_SKI1_1 | 56 | 60 | PF00082 | 0.627 |
| CLV_PCSK_SKI1_1 | 83 | 87 | PF00082 | 0.664 |
| DEG_APCC_DBOX_1 | 33 | 41 | PF00400 | 0.591 |
| DOC_PP1_RVXF_1 | 41 | 48 | PF00149 | 0.643 |
| DOC_USP7_UBL2_3 | 10 | 14 | PF12436 | 0.646 |
| DOC_USP7_UBL2_3 | 23 | 27 | PF12436 | 0.685 |
| DOC_USP7_UBL2_3 | 29 | 33 | PF12436 | 0.615 |
| DOC_USP7_UBL2_3 | 3 | 7 | PF12436 | 0.683 |
| LIG_14-3-3_CanoR_1 | 22 | 30 | PF00244 | 0.709 |
| LIG_14-3-3_CanoR_1 | 43 | 48 | PF00244 | 0.694 |
| LIG_FHA_2 | 67 | 73 | PF00498 | 0.602 |
| LIG_Integrin_RGD_1 | 34 | 36 | PF01839 | 0.604 |
| LIG_SH2_STAT5 | 84 | 87 | PF00017 | 0.710 |
| MOD_Cter_Amidation | 1 | 4 | PF01082 | 0.716 |
| MOD_GSK3_1 | 39 | 46 | PF00069 | 0.600 |
| MOD_N-GLC_1 | 43 | 48 | PF02516 | 0.640 |
| MOD_NEK2_1 | 39 | 44 | PF00069 | 0.586 |
| MOD_PKA_1 | 22 | 28 | PF00069 | 0.662 |
| MOD_PKB_1 | 20 | 28 | PF00069 | 0.633 |
| MOD_Plk_1 | 43 | 49 | PF00069 | 0.586 |
| TRG_ER_diArg_1 | 81 | 84 | PF00400 | 0.633 |
| TRG_NLS_MonoExtC_3 | 2 | 7 | PF00514 | 0.676 |
| TRG_NLS_MonoExtN_4 | 9 | 16 | PF00514 | 0.738 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0S4J235 | Bodo saltans | 75% | 81% |
| A0A3Q8IL65 | Leishmania donovani | 100% | 100% |
| A4HQ88 | Leishmania braziliensis | 93% | 100% |
| C9ZT84 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 66% | 100% |
| E9AU06 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
| Q9N861 | Leishmania major | 98% | 100% |
| V5BJ70 | Trypanosoma cruzi | 76% | 100% |